Dual-Diagnosis and Compulsory Treatment
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00970372 |
Recruitment Status :
Completed
First Posted : September 2, 2009
Last Update Posted : April 16, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The Norwegian Social and Welfare Act of 1992, opened for compulsory commitment of patients with serious alcohol and drug problems to inpatient care. Clinical research of compulsory committed dual diagnosed patients is to date unavailable and is demanded by the health authorities of Norway. Because there has been limited examination/screening and no post-treatment research efforts on this group of patients, the investigators have limited knowledge of the treatment as well as the patient group. Do compulsory treated patients differ from those voluntarily admitted? Does this type of treatment influence the patients' motivation to change their behaviour, and does the treatment effort lead to positive outcome effects in the long run?
The primary aim is to acquire new and in depth descriptive knowledge about the compulsory treated group of patients according to: Drug dependence, psychiatric and somatic co-morbidity and socio-demographic characteristics, and investigate whether the treatment yields the intended outcomes in terms of improved substance abuse measures.
A second aim is to compare the group with a corresponding group of voluntarily admitted patients within the same wards. A follow-up interview focusing on motivational issues within 6 months post treatment to evaluate the long-term results of the treatment is planned.
A quasi-experimental, prospective case-control study will be conducted. Compulsory committed patients in five counties during a two year period, will be compared to a group of voluntarily admitted patients. The groups will be compared regarding 1) description and screening 2) motivation to change and 3) outcome results after 6 months.
Both official authorities as well as clinical practitioners would benefit from valid Norwegian results and knowledge within this field to form further policies and evidence based best practice for this vulnerable group of patients.
Condition or disease |
---|
Substance-Related Disorders Dual Diagnosis |
Study Type : | Observational |
Actual Enrollment : | 202 participants |
Time Perspective: | Prospective |
Official Title: | Compulsory Treatment of Alcohol and Drug Dependent Patients and Dual Diagnosis in 5 Counties of Health Region South-East, Norway |
Study Start Date : | September 2008 |
Actual Primary Completion Date : | May 2012 |
Actual Study Completion Date : | May 2012 |

Group/Cohort |
---|
Involuntary patients
Compulsory treated patients according to the Norwegian Social and Welfare Act of 1992. Most patients have dualdiagnosis.
|
Voluntary patients
Voluntary patients on the same wards. Most patients have dual-diagnosis.
|
- Substance use outcomes measured by Europ-ASI Quality of Life [ Time Frame: 6 months after discharge ]
- Psychological distress (SCL-90-R) [ Time Frame: 6 months after discharge ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients with alcohol and substance use disorders
- Estimated premorbid IQ of 70 or higher
Exclusion Criteria:
- Active drug or alcohol abuse

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00970372
Norway | |
Sorlandet Hospital | |
Kristiansand, Vest Agder, Norway, 4604 |
Study Director: | Øistein Kristensen | Sørlandet Sykehus HF |
Responsible Party: | Sorlandet Hospital HF |
ClinicalTrials.gov Identifier: | NCT00970372 |
Other Study ID Numbers: |
SSHF_815360 |
First Posted: | September 2, 2009 Key Record Dates |
Last Update Posted: | April 16, 2014 |
Last Verified: | April 2014 |
Coercion |
Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |